Summary
Q Therapeutics , Inc.
Founded in 2004
Description
Therapeutics, Inc., a clinical-stage company, engages in developing human cell-based therapies intended to treat neurodegenerative diseases of the brain and spinal cord.
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
Weaknesses
- Q Therapeutics , Inc. has a very small market share in their industry
- Variance of revenue growth is more than the industry average
- Since Q Therapeutics , Inc. was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Q Therapeutics , Inc.'s annual revenue
$3635000
Based on Kona Equity data
-
Revenue per employee
$403889
-
Variance of revenue growth
97.6
-
Annual revenue growth since founding
$181750
-
Revenue growth rate from first known quarter to current
313.3%
Employee Count
9 employees
-
Employee growth rate from first known quarter to current
300.0%
Executives
James Campanelli
Vice President, Research & Development
j**@qthera.comTim Considine
Vice President, Clinical Operations
t**@qthera.comDeborah Eppstein
CEO
d**@qthera.comBrooke Hashimoto
Research Associate
b**@qthera.comTom Hicks
Business Development Officer
t**@qthera.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Longeveron LLC
longeveron.com- Founded in 2014
- Location: Miami, FL
- Annual Revenue: $1.3M
- Employees: 18
- Longeveron is a clinical stage biotechnology company developing cellular therapies for aging related and life threatening conditions. Their lead investigational product is Lomecel B, derived from culture expanded medicinal signaling cells (MSCs) sourc...
ReNeuron
reneuron.com- Founded in 1997
- Location: Pencoed, Bridgend
- Annual Revenue: $335.0K
- Employees: 38
- ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients...
Promethera Therapeutics
promethera.com- Founded in 2009
- Location: Mont-Saint-Guibert, Wallonia
- Annual Revenue: $12.7M
- Employees: 23
- Promethera is pioneering the development of cutting-edge cell-based therapies for the treatment of liver diseases to reduce the need for transplantation
Alzamend Neuro , Inc.
alzamend.com- Founded in 2015
- Location: Salt Lake City, UT
- Annual Revenue: $1.4M
- Employees: 4
- Alzamend Neuro is a clinical stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimers disease, Bipolar disorder, Major Depressive Disorder (MDD) and Post Traumatic Stress Disorder (PTSD). Our mission is ...
Brainstorm Cell Therapeutics
brainstorm-cell.com- Founded in 2000
- Location: New York City, NY
- Annual Revenue: $9.1M
- Employees: 43
- Discover. Innovate. Deliver.BrainStorm is a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases.LEARN MORE Phase 3 Pivotal Trial in ALS is Now Complete Read More Phase 2 Trial in Progressive ...
Caladrius Biosciences , Inc.
caladrius.com- Founded in 1980
- Location: Basking Ridge, NJ
- Annual Revenue: $5.7M
- Employees: 27
- Caladrius Biosciences (NASDAQ: CLBS) develops regenerative therapies that reverse chronic disease. Learn more about our cell therapy development.
Key Information
- Name: Q Therapeutics , Inc.
- Category: Biotechnology
- Industry: Corporate Office
- SIC: 28; 283
- NAICS: 32541; 541
See similar companies
-
By City Salt Lake City Small Corporate Office in Salt Lake City Mid-size Corporate Office in Salt Lake City Biotechnology in Salt Lake City Small Biotechnology in Salt Lake City Mid-size Biotechnology in Salt Lake City
-
By State UT Small companies in UT Biotechnology in UT Small Biotechnology in UT Mid-size Biotechnology in UT Small Corporate Office in UT Mid-size Corporate Office in UT
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Corporate Office Small Corporate Office Mid-size Corporate Office Biotechnology and Corporate Office
-
Firmographic data G Score of 3 Founded in 2004 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Q Therapeutics , Inc.'s headquarters are located at 615 Arapeen Dr. Ste. 102 Salt Lake City, UT 84108.
Q Therapeutics , Inc.'s official website is qthera.com
Q Therapeutics , Inc.'s annual revenue is $3.6 M.
Q Therapeutics , Inc.'s SIC: 28; 283
Q Therapeutics , Inc.'s NAICS: 32541; 541.
Q Therapeutics , Inc. has 9 employees
Q Therapeutics , Inc. is in the industry of Biotechnology.
